These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961 [TBL] [Abstract][Full Text] [Related]
5. Reducing the dose of smallpox vaccine reduces vaccine-associated morbidity without reducing vaccination success rates or immune responses. Couch RB; Winokur P; Edwards KM; Black S; Atmar RL; Stapleton JT; Kissner JM; Shinefield H; Denny TN; Bybel MJ; Newman FK; Yan L; J Infect Dis; 2007 Mar; 195(6):826-32. PubMed ID: 17299712 [TBL] [Abstract][Full Text] [Related]
14. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing. Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675 [TBL] [Abstract][Full Text] [Related]
15. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340 [TBL] [Abstract][Full Text] [Related]
16. Monitoring of human immunological responses to vaccinia virus. Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020 [TBL] [Abstract][Full Text] [Related]
17. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. Newman FK; Frey SE; Blevins TP; Mandava M; Bonifacio A; Yan L; Belshe RB J Clin Microbiol; 2003 Jul; 41(7):3154-7. PubMed ID: 12843056 [TBL] [Abstract][Full Text] [Related]
18. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination. Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity. He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325 [TBL] [Abstract][Full Text] [Related]
20. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation. Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]